Inhaled alpha 1 -proteinase inhibitor therapy in patients with cystic fibrosis
Amit Gaggar(University of Alabama at Birmingham), Scott H. Donaldson(University of North Carolina at Chapel Hill), Rhonda Griffin(Grifols (United States)), James F. Chmiel(Riley Hospital for Children), David E. Nichols(University of Nottingham), Patrick A. Flume(Medical University of South Carolina), Junliang Chen(Sun Yat-sen University), Henry L. Dorkin(Boston Children's Hospital)
Cited by 0
Related Papers
Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del<i>CFTR</i>
|New England Journal of Medicine|2015|1.6k
Neural correlates of the LSD experience revealed by multimodal neuroimaging
|Proceedings of the National Academy of Sciences|2016|880
Randomized Trial of Omalizumab (Anti-IgE) for Asthma in Inner-City Children
|New England Journal of Medicine|2011|870
Effect of VX-770 in Persons with Cystic Fibrosis and the G551D- <i>CFTR</i> Mutation
|New England Journal of Medicine|2010|802